CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
https://doi.org/10.15825/1995-1191-2014-4-68-71
Abstract
Multiple sclerosis (MS) is a major infl ammatory and demyelinating disease of the central nervous system (CNS), associated with a broad spectrum of physical, psychological, and social impairments. High-dose immunosuppressive therapy (HDIT) with autologous hematopoietic stem cell transplantation (AHSCT) is a new and promising approach to MS treatment. In this paper we present the clinical monitoring results of 93 patients with different MS types after AHSCT. The mobilization and transplantation procedures were well tolerated. At long-term
follow-up (mean 47,2 months), the overall clinical response in terms of disease improvement or stabilization was 95% in patients with relapsing-remitting MS and 77,5% in patients with progressive MS. The results of our study support the feasibility of AHSCT in MS patients.
About the Authors
D. A. Fedorenko
N.I. Pirogov National Medical Surgical Center of the Ministry of Healthcare of the Russian Federation,
Moscow, Russian Federation
Russian Federation
Russian Federation
V. Ya. Melnichenko
N.I. Pirogov National Medical Surgical Center of the Ministry of Healthcare of the Russian Federation,
Moscow, Russian Federation
Russian Federation
Russian Federation
T. I. Ionova
N.I. Pirogov National Medical Surgical Center of the Ministry of Healthcare of the Russian Federation,
Moscow, Russian Federation
Russian Federation
Russian Federation
E. B. Yaroshenko
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
Russian Federation
Russian Federation
1, Shchukinskaya st., Moscow, 123182, Russian Federation. Теl. 8 (495) 190-35-62
References
1. Новик АА, Богданов АН. Принципы трансплантации костного мозга и стволовых клеток периферической крови. СПб.: ВМА, 2001. Novik AA, Bogdanov AN. Printsipy transplantatsii kostnogo mozga i stvolovykh kletok perifericheskoy krovi. SPb.: VMA, 2001.
2. Шевченко ЮЛ, Новик АА, Кузнецов АН и др. Аутологичная трансплантация кроветворных стволовых клеток при рассеянном склерозе: результаты исследования Российской кооперативной группы клеточной терапии. Неврол. журн. 2008; 2: 11–18. Shevchenko YuL, Novik AA, Kuznetsov AN i dr. Autologichnaya transplantatsiya krovetvornykh stvolovykh kletok pri rasseyannom skleroze: rezul'taty issledovaniya Rossiyskoy kooperativnoy gruppy kletochnoy terapii. Nevrol. zhurn. 2008; 2: 11–18.
3. Burt RK, Cohen B, Rose J et al. Hematopoietic stem cell transplantation for multiple sclerosis. Arch Neurol. 2005; 62: 860–864.
4. Chen B, Zhou M, Ouyang J et al. Long-term effi cacy of autologous haematopoietic stem cell transplantation in multiple sclerosis at a single institution in China. Neurol. Sci. 2012; 33 (4): 881–886.
5. Comi G et al. Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. J. Neurol. 2000; 247: 376–382.
6. Fassas A, Passweg JR, Anagnostopoulos A et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J. Neurol. 2002; 249: 1088–1097.
7. Hamerschlak N, Rodrigues M, Moraes DA et al. Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG. Bone Marrow Transplant. 2010; 45: 239–248.
8. Krasulova E, Trneny M, Kozak T et al. High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience. Mult. Scler. 2010; 16: 685–693.
9. Marmont AM. Will hematopoietic stem cell transplantation cure human autoimmune diseases? J. Autoimmunity. 2008; 30: 145–150.
10. Rogojan C, Frederiksen JL. Hematopoietic stem cell transplantation in multiple sclerosis. Acta Neurol. Scand. 2009; 120: 371–382.
11. Saccardi R, Kozak T, Bocelli-Tyndall C et al. Autoimmune Diseases Working Party of EBMT. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult. Scler. 2006; 12 (6): 814–823.
12. Шумаков ВИ, Шевченко ОП, Онищенко НА. Трансплантация аутологичных клеток костного мозга больным с сердечной недостаточностью: молекулярные механизмы и маркеры эффективности лечения. Молекулярная медицина. 2006; 2: 48–54. Shumakov VI, Shevchenko OP, Onishhenko NA. Transplantacija autologichnyh kletok kostnogo mozga bol'nym s serdechnoj nedostatochnost'ju: molekuljarnye mehanizmy i markery jeffektivnosti lechenija. Molekuljarnaja medicina. 2006; 2: 48–54.
13. Курабекова РМ, Луговская СА, Наумова ЕВ, Цирульникова ОМ, Цирульникова ИЕ, Гичкун ОЕ и др. Aнализ связи количества гемопоэтических стволовых клеток крови с лабораторными показателями состояния гепатобилиарной системы у детей с врожденными и наследственными заболеваниями печени. Клиническая лабораторная диагностика. 2012; 7:28–31. Kurabekova RM, Lugovskaja SA, Naumova EV, Cirul'nikova OM, Cirul'nikova IE, Gichkun OE i dr. Analiz svjazi kolichestva gemopojeticheskih stvolovyh kletok krovi s laboratornymi pokazateljami sostojanija gepatobiliarnoj sistemy u detej s vrozhdennymi i nasledstvennymi zabolevanijami pecheni. Klinicheskaja laboratornaja diagnostika. 2012; 7: 28–31.
14. Shevchenko YL, Novik AA, Afanasiev BV et al. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis. Exp. Hemat. 2008; 36 (8): 922–928.
Review
For citations:
Fedorenko D.A., Melnichenko V.Ya., Ionova T.I., Yaroshenko E.B. CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS. Russian Journal of Transplantology and Artificial Organs. 2014;16(4):68-71. (In Russ.) https://doi.org/10.15825/1995-1191-2014-4-68-71
Views:
2048
Email this article 